"Thromboelastography" Pronounce,Meaning And Examples

"Thromboelastography" Natural Recordings by Native Speakers

Thromboelastography

"Thromboelastography" Meaning

Thromboelastography is a medical diagnostic test used to evaluate the viscoelastic properties of blood clotting. It measures the cooperativity of coagulation, or how well the various clotting factors work together to produce a blood clot. The test is based on the principles of rotational tests and measures the change in the physical properties of the clot as it forms.

"Thromboelastography" Examples

Thromboelastography Usage Examples

1. Medical Research

In a study published in the Journal of Thrombosis and Haemostasis, researchers used thromboelastography to assess the coagulation profiles of patients with sepsis.

2. Clinical Setting

The doctor ordered a thromboelastograph to evaluate the patient's blood clotting function, which indicated an abnormal coagulopathy.

3. Academic Paper

Title: The application of thromboelastography in trauma patients: A systematic review. This article examined the utility of thromboelastography in identifying patients at risk of bleeding complications.

4. Conference Presentation

During the American Thrombosis and Hemostasis conference, a speaker discussed the use of thromboelastography as a bedside tool for monitoring patients undergoing emergent surgical procedures.

5. Scientific Experiment

In a laboratory study, scientists used thromboelastography to investigate the effects of different anticoagulant medications on blood clot formation.

"Thromboelastography" Similar Words

Thrombocytopaenia

Thrombocytopaenia, also known as thrombocytopenia, is a condition characterized by an abnormally low level of platelets in the blood. Platelets are small blood cells that play a crucial role in blood clotting and stopping bleeding when a blood vessel is injured.

Thrombocytopaenic

Thrombocytopaenic refers to a medical condition characterized by a low platelet count (thrombocytopenia).

Thrombocytopathy

Thrombocytopenia

Thrombocytopenias

Thrombocytopenic

Thrombocytopenic refers to a medical condition characterized by a low platelet count in the blood, often resulting in an increased risk of bleeding or bruising.

Thrombocytopoiesis

Thrombocytopoiesis refers to the process of forming and developing platelets, which are small blood cells that play a crucial role in blood clotting. It is a complex process that involves the production of platelets from hematopoietic stem cells in the bone marrow, through a series of maturation steps, before they are released into the bloodstream.

Thrombocytosis

Thromboembolic

Relating to the formation of a blood clot (thrombus) in a vein or artery that breaks loose and travels to another part of the body, where it can block circulation and cause a serious medical condition, often leading to a stroke or heart attack.

Thromboembolism

A blood clot (thrombus) that breaks loose and travels through the bloodstream until it lodges in a narrower part of a blood vessel, blocking the flow of blood. This condition can occur in the brain, lungs, heart, or other parts of the body and can be life-threatening.

Thromboembolytic

Thromboembolic refers to the formation of a blood clot (thrombus) that breaks loose, travels through the bloodstream, and lodges in another part of the body, causing a blockage (embolism). In medical terms, a thromboembolism occurs when a blood clot forms in a vein or an artery and travels through the bloodstream until it gets stuck, blocking normal blood flow to an organ or tissue. Examples: Pulmonary embolism: a blood clot in the lungs Cerebral embolism: a blood clot in the brain Deep vein thrombosis (DVT): a blood clot in the deep veins of the legs

Thrombogenesis

Thrombogenesis refers to the formation or creation of a blood clot. It's a crucial process in the body, but excessive or abnormal thrombogenesis can lead to various health issues such as cardiovascular diseases, strokes, and pulmonary embolism.

Thrombogenic

Thrombogenic refers to the tendency of a substance, surface, or event to induce the formation of a blood clot (thrombus). In other words, it's the capacity to promote the creation of a blood clot, which can lead to blockages in blood vessels and potentially cause serious health problems, such as thrombosis or ischemia. This term is often used in medical and biomedical contexts to describe materials, devices, or situations that may increase the risk of blood clotting.

Thrombogenicity

The term "thrombogenicity" refers to the tendency of a substance or material to promote the formation of thrombi (blood clots) or thrombosis, i.e., the process of blood clotting. In medical and scientific contexts, thrombogenicity is often discussed in terms of the risk of venous or arterial thrombosis, and is associated with various factors such as materials, devices, and drugs that may interact with the blood coagulation cascade. In a broader sense, thrombogenicity can also refer to the ability of a material to cause blood clotting or thrombosis in a biological system, such as a wound or an implant.

Thrombokinase

Thrombokinase is an enzyme involved in the process of blood clotting. It activates prothrombin, a protein in the blood, to form thrombin, which then converts fibrinogen into fibrin to form blood clots.

Thrombolic

The word "thrombolic" refers to a substance or agent that promotes the formation of blood clots (thrombi) or contributes to thrombosis, which is the process of blood clotting. This term is often used in medical contexts. There are two main types of thrombolic agents: 1. Thrombolytic agents: These are substances that dissolve existing blood clots, such as alteplase or streptokinase, which are used to treat acute ischemic stroke, pulmonary embolism, and myocardial infarction. 2. Thrombogenic agents: These are substances that increase the tendency of blood to clot, such as those found in certain medical devices or materials that may come into contact with the bloodstream. In both cases, thrombolic refers to the promotion of thrombosis, either by dissolving or forming blood clots.